ACETYLCHOLINE-RECEPTOR ANTIBODIES IN PRIMARY BILIARY-CIRRHOSIS - CHARACTERIZATION OF ANTIGEN AND IDIOTYPIC SPECIFICITY

被引:11
作者
SUNDEWALL, AC [1 ]
LEFVERT, AK [1 ]
机构
[1] KAROLINSKA HOSP,DEPT MED,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1111/j.1365-3083.1990.tb02795.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Auto‐antibodies against the acetylcholine receptor of skeletal muscle are considered to be the cause of the neuromuscular dysfunction in myasthenia gravis. However, such auto‐anlibodies also occur in disease states not accompanied by neuromuscular symptoms. Patients with primary biliary cirrhosis have a high prevalence of different auto‐antibodies, including antibodies against the acetylcholine receptor. In primary biliary cirrhosis, these anti‐receptor antibodies are predominantly of IgM isotype. The IgM antibodies show a broader reactivity with receptors from other species than antibodies from myasthenic patients, Immunoglobulins from patients with primary biliary cirrhosis bear the same receptor antibody‐associated idiotypes, but ihe repertoire is quantitatively different from that found in myasthenia gravis patients. The IgM receptor antibody activity in a serum from a patient with primary biliary cirrhosis could be inhibited by cardiolipin, poly [dT], poly[I], and ssDN A, whereas this antibody activity in serum from a patient with myasthenia gravis was slightly reduced only by cardiolipin. Generally, IgM antibodies from patients with primary biliary cirrhosis had a broader reactivity with polynucleotides and phospholipids than IgG antibodies and antibodies from patients with myasthenia gravis. These results indicate a difference in the fine specificity between acetylcholine receptor antibodies in primary biliary cirrhosis and in myasthenia gravis. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:477 / 484
页数:8
相关论文
共 14 条
[1]  
CULP KS, 1982, MAYO CLIN PROC, V57, P365
[2]   HUMAN MONOCLONAL IMMUNOGLOBULINS THAT BIND THE HUMAN ACETYLCHOLINE-RECEPTOR [J].
ENG, H ;
LEFVERT, AK ;
MELLSTEDT, H ;
OSTERBORG, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (12) :1867-1869
[3]   SKELETAL-MUSCLE ANTIBODIES IN PATIENTS WITH A THYMIC TUMOR BUT WITHOUT MYASTHENIA-GRAVIS [J].
GILHUS, NE ;
AARLI, JA ;
JANZEN, RWC ;
OTTO, HF ;
FASSKE, E ;
MATRE, R .
JOURNAL OF NEUROIMMUNOLOGY, 1985, 8 (2-3) :69-78
[4]   ANTI-IDIOTYPIC ANTIBODIES, ACETYLCHOLINE-RECEPTOR ANTIBODIES AND DISTURBED NEUROMUSCULAR FUNCTION IN HEALTHY RELATIVES TO PATIENTS WITH MYASTHENIA-GRAVIS [J].
LEFVERT, AK ;
PIRSKANEN, R ;
SVANBORG, E .
JOURNAL OF NEUROIMMUNOLOGY, 1985, 9 (1-2) :41-53
[5]   RECEPTOR-LIKE ACTIVITY OF A MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AGAINST AN ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY [J].
LEFVERT, AK ;
FULPIUS, BW .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1984, 19 (05) :485-489
[6]   DETERMINATION OF ACETYLCHOLINE-RECEPTOR ANTIBODY IN MYASTHENIA-GRAVIS - CLINICAL USEFULNESS AND PATHOGENETIC IMPLICATIONS [J].
LEFVERT, AK ;
BERGSTROM, K ;
MATELL, G ;
OSTERMAN, PO ;
PIRSKANEN, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1978, 41 (05) :394-403
[7]  
LEFVERT AK, 1987, NEW ENGL J MED, V317, P170
[8]  
LEFVERT AK, 1976, EUR J CLIN INVEST, V7, P115
[9]  
LEFVERT AK, 1985, CONCEPTS IMMUNOPATHO, P285
[10]  
LINDSTROM J, 1974, METHOD ENZYMOL, P432